Rebalix
Logo LGIMLGIM · sheet of 10 September 2026
ETF sheet · official issuer and register data

L&G Russell 2000 US Small Cap Quality UCITS ETF

RTWO · IE00B3CNHJ55 · class USD Acc. · USD · domicile Ireland
Equity · United StatesSFDR art. 6 (inferred)
Index tracked: Russell 2000® Index Net TR USD
TER
0.30%+ trans. 0.07%
Fund size
189 m EUR
Tracking difference
−0.10%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical (sampled)
Income
Accumulating
Launch 25 Sept 2008 · costs from the KID as of 2 Sept 2026 · 0 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The investment objective of the Fund is to provide exposure to U.S. small cap companies that are weighted according to their size and quality characteristics. The Fund is passively managed and aims to track the performance of the Russell 2000 0.4 Quality Target Exposure Factor Net Tax Index (the “Index”), before the deduction of fees and expenses. The Index is designed to provide exposure to small capitalisation companies in the United States, with an emphasis on quality characteristics, in accordance with its methodology. The Fund seeks to achieve its…

Performance since series start (in euro) — base 100

29 Jul 201631 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2017201920212023202527885272
High 278 (2 Jul 2026) · low 85 (18 Mar 2020) · last 272. Past performance is not indicative of future results.

Returns in euro

1 year+31.5%
3 years+43.9%
5 years+50.6%
10 years+172.4%
Since series start+172.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)17.17%19.77%21.02%
Max drawdown−9.53%−26.39%−29.90%
Sharpe1.150.730.33
Sortino1.741.090.47
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · RTWO · IE00B3CNHJ551
RebalixRTWO · IE00B3CNHJ55 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+11.06%+11.11%−0.05%
2024+10.19%+10.38%−0.20%
2023+18.05%+18.09%−0.04%
2022−18.58%−18.60%+0.01%
2021+19.56%+19.93%−0.37%

Holdings

Portfolio as declared by the issuer · 30 Jun 2026 · 0 securities · top-10 weight = 5.2%
Top holdingsWeight
Moelis & Company0.7%
Brinker International0.7%
Dave Inc0.6%
Krystal Biotech0.6%
Alkermes0.5%
CareTrust REIT0.5%
Brightspring Health Services0.4%
InterDigital0.4%
Silicon Labs0.4%
Terreno Realty0.4%
Countries (% of fund)
Stati Uniti100.0%
Sectors (% of fund)
Finanziari20.7%Assistenza sanitaria19.1%Industriali14.0%Informatica12.8%Beni di consumo voluttuari9.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
RTWO · Borsa Italiana (ETFplus), Euronext Amsterdam
ETLZ · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 14 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fundcentres.landg.com/srp/documents-id/cdd52ae6-9868-47c4-aeb1-2a1c16f
Factsheet · fundcentres.landg.com/srp/documents-id/e967e44a-e2f9-4298-8a14-e9d3154
Prospectus · fundcentres.landg.com/srp/lit/7qeQjP/Prospectus_Legal-General-UCITS-ET
The live sheet, always up to date
rebalix.com/en/etf/IE00B3CNHJ55
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · RTWO · IE00B3CNHJ552